Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients

Total article views   Abstract views HTML views PDF downloads Totals
6,764 Dovepress* 4,178 780+ 1,936 4,958
PubMed Central* 0 1,806 362 1,806
Totals 4,178 2,586 2,298 6,764
*Since 31 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar